Question-and-Answer Session
Operator
(Operator Instructions). Our first question comes from the line of Mark Mullikin - Piper Jaffray.
John Crowther – Piper Jaffray
Hi, this is John on for Mark Mullikin. Couple of quick questions. I saw you ramped up the sales force in the fourth quarter. Do you have any more plans for sales force expansion in 2008?
Donald Earhart
We ramped up in the first quarter.
John Crowther – Piper Jaffray
So the 210 was this first quarter.
Donald Earhart
Yes, so we are basically where we want to be; we are very close.
John Crowther – Piper Jaffray
Okay, so no further huge expansion plans for the rest of this year?
Donald Earhart
No, we’ve ramped up less than 15%. By the way, John, that includes clinical people as well as sales people; that’s not all sales people.
John Crowther – Piper Jaffray
All right, okay. Second question is, do you know what interest rate you’re earning on the cash you’ve got from the InfuSystem sale?
Donald Earhart
It’s over 10%.
John Crowther – Piper Jaffray
Okay. Where are you currently holding that cash, like what sort of securities?
Donald Earhart
Very safe ones.
John Crowther – Piper Jaffray
Okay.
Donald Earhart
We don’t have any Bear Stearns stock.
John Crowther – Piper Jaffray
Do you know if you have auction rate securities in there?
Donald Earhart
No, we do not.
John Crowther – Piper Jaffray
Good to know. Another one more quick question for you and then I’ll let everyone else hop on here. You mentioned a couple of quick product launches in 2008. Beyond those, do you have any others that you are currently planning to introduce in 2008?
Donald Earhart
We have several other projects right now in the development stage, which may generate products before the end of the year, but because they are still in the development stage, we don’t want to talk about those yet.
John Crowther – Piper Jaffray
Okay, great. I will hop back in queue, thank you.
Operator
Our next question comes from the line of Adrian Dawes - Hartwell.
Adrian Dawes - Hartwell
Thanks for taking my call. Couple of questions surrounding your thoughts for 2008 and the guidance you gave. Can you talk a little bit about the impact of the infection requirement on hospitals and how you thought about that as giving guidance?
Donald Earhart
Adrian, the reason for buying AcryMed was heavily influenced by the change in the law, which takes place in October of this year. So everything we are doing on the AcryMed side will go towards supporting that change in the law and hopefully make us very attractive to hospitals with the kind of products we are going to bring them.
- To read the full transcript on Seeking Alpha, click here »
